REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-11-30

Reporting Person: ROBERTS WILLIAM (VP Regulat Dev & Med Safety)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-05	Common Stock	G	26000.0	$0.0	Disposed	16644.0	Direct
2012-11-27	Common Stock	G	11500.0	$0.0	Acquired	11500.0	Indirect
2012-11-30	Common Stock	S	224.0	$177.43	Disposed	11276.0	Indirect
2012-11-30	Common Stock	S	430.0	$178.27	Disposed	10846.0	Indirect
2012-11-30	Common Stock	S	2600.0	$179.43	Disposed	8246.0	Indirect
2012-11-30	Common Stock	S	5010.0	$180.67	Disposed	3236.0	Indirect
2012-11-30	Common Stock	S	1515.0	$181.47	Disposed	1721.0	Indirect
2012-11-30	Common Stock	S	521.0	$182.44	Disposed	1200.0	Indirect
2012-11-30	Common Stock	S	800.0	$183.58	Disposed	400.0	Indirect
2012-11-30	Common Stock	S	200.0	$184.29	Disposed	200.0	Indirect
2012-11-30	Common Stock	S	200.0	$186.0	Disposed	0.0	Indirect
2012-09-04	Common Stock	G	19947.0	$0.0	Acquired	19947.0	Indirect
2012-11-05	Common Stock	G	26000.0	$0.0	Acquired	45947.0	Indirect
2012-11-27	Common Stock	G	11500.0	$0.0	Disposed	17447.0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17000.0	Indirect
Common Stock	1200.0	Indirect
Common Stock	4331.0	Indirect
Common Stock	1200.0	Indirect

Footnotes

F1: Gift of Common Stock by reporting person to spouse.

F2: Transfer of Common Stock by spouse to Charitable Remainder Unitrust (CRUT).

F3: Represents volume-weighted average price of sales of 224 shares of Company stock on November 30, 2012 at prices ranging from $177.42 to $177.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F4: Represents volume-weighted average price of sales of 430 shares of Company stock on November 30, 2012 at prices ranging from $178.03 to $178.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F5: Represents volume-weighted average price of sales of 2,600 shares of Company stock on November 30, 2012 at prices ranging from $179.05 to $179.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F6: Represents volume-weighted average price of sales of 5,010 shares of Company stock on November 30, 2012 at prices ranging from $180.02 to $180.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F7: Represents volume-weighted average price of sales of 1,515 shares of Company stock on November 30, 2012 at prices ranging from $181.00 to $181.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F8: Represents volume-weighted average price of sales of 521 shares of Company stock on November 30, 2012 at prices ranging from $182.14 to $182.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F9: Represents volume-weighted average price of sales of 800 shares of Company stock on November 30, 2012 at prices ranging from $183.21 to $183.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.

F10: Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $184.16 to $184.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.